Quanterix Corporation Paid-in-Kind Interest
Quanterix Corporation (QTRX) reported Paid-in-Kind Interest of $65.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-06.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2023-03-06
- Quanterix Corporation paid-in-kind interest for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Quanterix Corporation paid-in-kind interest for the quarter ending 2021-09-30 was $22.00K, a 0.00% change year-over-year.
- Quanterix Corporation paid-in-kind interest for the quarter ending 2021-06-30 was $21.00K, a 0.00% change year-over-year.
- Quanterix Corporation paid-in-kind interest for the quarter ending 2021-03-31 was $22.00K, a 0.00% change year-over-year.
- Quanterix Corporation paid-in-kind interest for fiscal 2021 was $65.00K, a 24.42% decline from fiscal 2020.
- Quanterix Corporation paid-in-kind interest for fiscal 2020 was $86.00K, a 3.37% decline from fiscal 2019.
- Quanterix Corporation paid-in-kind interest for fiscal 2019 was $89.00K, a 47.65% decline from fiscal 2018.
- Quanterix Corporation paid-in-kind interest for fiscal 2018 was $170.00K, a 28.57% decline from fiscal 2017.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $22.00K derived: sum of 2 quarters · filed 2023-03-06 | $43.00K derived: sum of 3 quarters · filed 2023-03-06 | $65.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $43.00K derived: sum of 2 quarters · filed 2022-08-08 | $65.00K 10-Q · filed 2021-11-04 | $86.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $43.00K 10-Q · filed 2022-08-08 | $64.00K derived: sum of 3 quarters · filed 2023-03-06 | $86.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-10 | $43.00K derived: sum of 2 quarters · filed 2023-03-06 | $65.00K derived: sum of 3 quarters · filed 2023-03-06 | $86.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $43.00K derived: sum of 2 quarters · filed 2023-03-06 | $64.00K derived: sum of 3 quarters · filed 2023-03-06 | $86.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $43.00K derived: sum of 2 quarters · filed 2021-11-04 | $65.00K 10-Q · filed 2021-11-04 | $86.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $43.00K 10-Q · filed 2021-08-05 | $64.00K derived: sum of 3 quarters · filed 2022-03-01 | $86.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-06 | $43.00K derived: sum of 2 quarters · filed 2022-03-01 | $65.00K derived: sum of 3 quarters · filed 2022-03-01 | $87.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $43.00K derived: sum of 2 quarters · filed 2022-03-01 | $65.00K derived: sum of 3 quarters · filed 2022-03-01 | $89.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $44.00K derived: sum of 2 quarters · filed 2020-11-06 | $68.00K 10-Q · filed 2020-11-06 | $105.00K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $46.00K 10-Q · filed 2020-08-04 | $83.00K derived: sum of 3 quarters · filed 2021-03-05 | $117.00K derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $24.00K 10-Q · filed 2020-05-07 | $61.00K derived: sum of 2 quarters · filed 2021-03-05 | $95.00K derived: sum of 3 quarters · filed 2021-03-05 | $141.00K derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $71.00K derived: sum of 2 quarters · filed 2021-03-05 | $117.00K derived: sum of 3 quarters · filed 2021-03-05 | $170.00K 10-K · filed 2021-03-05 |
| 2018-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $80.00K derived: sum of 2 quarters · filed 2019-11-08 | $133.00K 10-Q · filed 2019-11-08 | $188.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $99.00K 10-Q · filed 2019-08-06 | $154.00K derived: sum of 3 quarters · filed 2020-03-13 | $208.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $53.00K 10-Q · filed 2019-05-10 | $108.00K derived: sum of 2 quarters · filed 2020-03-13 | $162.00K derived: sum of 3 quarters · filed 2020-03-13 | $216.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $109.00K derived: sum of 2 quarters · filed 2020-03-13 | $163.00K derived: sum of 3 quarters · filed 2020-03-13 | $238.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $108.00K derived: sum of 2 quarters · filed 2018-11-07 | $183.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $129.00K 10-Q · filed 2018-08-10 | ||
| 2017-03-31 | $75.00K 10-Q · filed 2018-05-15 | |||
| 2016-12-31 | $388.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |